SHAWN KOSER: Open Payments
NPI 1154025773 · COLUMBUS, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$421 in 20 payments from 13 companies in 2025. Trend: 2023 $204 · 2024 $244 · 2025 $421
Food & beverage: $421
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 2 | $55 |
| AstraZeneca Pharmaceuticals LP | 3 | $54 |
| Dexcom, Inc. | 2 | $54 |
| Novo Nordisk Inc | 3 | $48 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $32 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $23 |
| Phathom Pharmaceuticals, Inc. | 1 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $22 |
| Novartis Pharmaceuticals Corporation | 1 | $22 |
Products named: Veozah, Dexcom G6 Transmitter, Kerendia, CAPLYTA, BREZTRI, JOURNAVX, VOQUEZNA, TRINTELLIX.
Industry payments across OH — which companies pay providers there.
